** Shares of medical device maker Becton Dickinson and Co
BDX.N up 1.4% at $257.30
** Co posts Q1 revenue of $4.59 bln, beating analysts'
average estimate of $4.52 bln, per Refinitiv data
** Reports Q1 adj. profit of $2.98/shr vs mean est.
$2.68/shr - Refinitiv
** Sees FY23 adj profit in range $12.07/shr-$12.32/shr,
above mean est. of $11.95/shr - Refinitiv
** Sees FY23 rev. in range $19.1 bln-$19.3 bln, above mean
est. $18.82 bln - Refinitiv
** Stock has risen 3% in last 12 months
(Reporting by Aditya Samal)
((Aditya.Samal@thomsonreuters.com;))